JPH0698881A - Pulse oximeter - Google Patents
Pulse oximeterInfo
- Publication number
- JPH0698881A JPH0698881A JP4249622A JP24962292A JPH0698881A JP H0698881 A JPH0698881 A JP H0698881A JP 4249622 A JP4249622 A JP 4249622A JP 24962292 A JP24962292 A JP 24962292A JP H0698881 A JPH0698881 A JP H0698881A
- Authority
- JP
- Japan
- Prior art keywords
- light
- frequency
- signal
- low
- infrared light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
(57)【要約】
【目的】 周波数成分を含む外来光がプローブのフォト
ダイオードに混入する場合でも、この光雑音の影響を効
果的に除去し、正確な酸素飽和度を測定できるようにす
る。
【構成】 動脈血流を含む生体組織6に赤色光と赤外光
をそれぞれ照射する発光ダイオード3,5と、赤色光の
照射を所定周波数でn回断続したあとに、赤外光の照射
を同周波数でn回断続するというタイミングで、2つの
光が生体組織6に照射されるように発光ダイオード3,
5を制御する制御回路1と、生体組織6によって吸光さ
れたあとの赤色光と赤外光の出力を検出するフォトダイ
オード7と、このフォトダイオード7の受光信号を増幅
する増幅器8と、この増幅器8の出力信号から所定の低
域遮断周波数で低域成分を除去する低域除去回路9と、
この低域除去回路9の出力信号を検波したあとの信号か
ら2波長についての動脈血流による吸光度の脈動成分の
比Φを算出するとともに、得られた吸光度の比Φから動
脈血の酸素飽和度Sを算出する演算回路1とを有する。
(57) [Abstract] [Purpose] Even when extraneous light including frequency components is mixed in the photodiode of the probe, the effect of this optical noise is effectively removed, and accurate oxygen saturation can be measured. [Structure] Light-emitting diodes 3 and 5 for respectively irradiating a living tissue 6 including arterial blood flow with red light and infrared light, and irradiation of infrared light after intermittent irradiation of red light at a predetermined frequency n times The light emitting diode 3, so that two lights are irradiated to the living tissue 6 at the timing of intermittently n times at the same frequency.
5, a control circuit 1 for controlling 5, a photodiode 7 for detecting outputs of red light and infrared light after being absorbed by the living tissue 6, an amplifier 8 for amplifying a light reception signal of the photodiode 7, and this amplifier A low-frequency removing circuit 9 for removing low-frequency components from the output signal of 8 at a predetermined low-frequency cutoff frequency;
The ratio Φ of the pulsating components of the absorbance due to the arterial blood flow for the two wavelengths is calculated from the signal obtained by detecting the output signal of the low-frequency elimination circuit 9, and the oxygen saturation S of the arterial blood is calculated from the obtained ratio Φ of the absorbance. And an arithmetic circuit 1 for calculating
Description
【0001】[0001]
【産業上の利用分野】本発明は生体における赤色光と赤
外光の異なる2つの波長の吸光特性の差を利用して被験
者の動脈血の酸素飽和度を非観血的に連続測定するため
のパルスオキシメータに関し、特に外来光によるノイズ
の影響を効果的に除去できるようにしたパルスオキシメ
ータに関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention utilizes non-invasive continuous measurement of oxygen saturation of arterial blood of a subject by utilizing the difference in absorption characteristics of two different wavelengths of red light and infrared light in a living body. The present invention relates to a pulse oximeter, and more particularly to a pulse oximeter capable of effectively removing the influence of noise caused by external light.
【0002】[0002]
【従来の技術】動脈血の酸素飽和度を非観血的に連続測
定するには、従来からパルスオキシメータが用いられて
いる。このパルスオキシメータでは、プローブを被験者
の指先や耳朶に装着し、プローブから赤と赤外の異なる
波長の光を生体に時分割に照射して、異なる2波長の透
過光または反射光から得られる吸光度の脈動成分の比Ф
から酸素飽和度Sを測定するものである。赤色光にはた
とえば660nmの基準波長が用いられるとともに、赤
外光にはたとえば940nmの波長が用いられ、プロー
ブ内にはこれらの波長を発する2つの発光ダイオードと
受光用の1つのフォトダイオードが内蔵されている。い
ま、赤色光の波長の吸光度の脈動成分をΔA1、赤外光
の波長の吸光度の脈動成分をΔA2とすると、異なる2
波長の吸光度の比Фは、次式で与えられる。 Ф=ΔA1/ΔA2 酸素飽和度Sは、この吸光度の比Фの関数fとして算出
することができる。 S=f(Ф)2. Description of the Related Art A pulse oximeter has been conventionally used for non-invasive continuous measurement of oxygen saturation of arterial blood. In this pulse oximeter, a probe is attached to a fingertip or an earlobe of a subject, and light of different wavelengths of red and infrared is radiated from a probe to a living body in a time-sharing manner to obtain transmitted or reflected light of two different wavelengths Ratio of pulsating component of absorbance Φ
Is to measure the oxygen saturation S. A reference wavelength of, for example, 660 nm is used for red light, and a wavelength of, for example, 940 nm is used for infrared light. Two light emitting diodes emitting these wavelengths and one photodiode for receiving light are built in the probe. Has been done. Now, assuming that the pulsation component of the absorbance of the red light wavelength is ΔA1 and the pulsation component of the absorbance of the infrared light wavelength is ΔA2, different 2
The wavelength absorption ratio Φ is given by the following equation. Φ = ΔA1 / ΔA2 The oxygen saturation S can be calculated as a function f of this absorbance ratio Φ. S = f (Φ)
【0003】ところで、このようなパルスオキシメータ
では、測定中にプローブのフォトダイオードに室内照明
などからの外来光が飛び込むと、測定信号に光雑音によ
るノイズ成分が混入してしまい、正確に酸素飽和度Sを
測定できなくなる。そこで、このような外来光によるノ
イズの影響を除去する試みが従来からいろいろとなされ
ている。たとえば図4に示すパルスオキシメータでは、
電圧シフト回路42を用いてこの外来光によるノイズの
影響を軽減できるようにしたものである。以下、このパ
ルスオキシメータの構成と動作を説明する。この図で、
プローブに内蔵された発光ダイオード3は赤色発光用の
ダイオードであり、発光ダイオード5は赤外発光用のダ
イオードである。これら発光ダイオード3,5には直流
電源Vc が接続されているとともに、駆動用のトランジ
スタ2,4がそれぞれ直列に接続されている。マイクロ
コンピュータなどから構成される演算・制御回路41か
らは、図5(a)に示す赤色光発光用の制御信号K1が
トランジスタ2のベースに出力され、図5(b)に示す
赤外光発光用の制御信号K2がトランジスタ4のベース
に出力される。制御信号K1,K2はたとえば250H
zの周波数を有しており、これらの制御信号K1,K2
によってトランジスタ2,4が交互にオン・オフされる
ことで、発光ダイオード3,4が2msecの周期で交
互に発光する。このプローブから発せられた赤色光およ
び赤外光は、動脈血流を含む被験者の生体組織6に入光
され、この生体組織6で吸光されたあとの透過光または
反射光がプローブ内に設けられた受光素子のフォトダイ
オード7によって検出される。By the way, in such a pulse oximeter, when external light from indoor lighting or the like enters the photodiode of the probe during measurement, a noise component due to optical noise is mixed into the measurement signal, and oxygen saturation is accurately achieved. The degree S cannot be measured. Therefore, various attempts have conventionally been made to remove the influence of noise due to such external light. For example, in the pulse oximeter shown in FIG.
The voltage shift circuit 42 is used to reduce the influence of noise due to this external light. The configuration and operation of this pulse oximeter will be described below. In this figure,
The light emitting diode 3 built in the probe is a diode for emitting red light, and the light emitting diode 5 is a diode for emitting infrared light. A DC power supply Vc is connected to the light emitting diodes 3 and 5, and driving transistors 2 and 4 are connected in series. A control signal K1 for red light emission shown in FIG. 5A is output to the base of the transistor 2 from the arithmetic / control circuit 41 composed of a microcomputer and the like, and infrared light emission shown in FIG. A control signal K2 for is output to the base of the transistor 4. The control signals K1 and K2 are, for example, 250H
has a frequency of z and these control signals K1, K2
Thus, the transistors 2 and 4 are alternately turned on and off, so that the light emitting diodes 3 and 4 emit light alternately in a cycle of 2 msec. The red light and infrared light emitted from this probe enter the living tissue 6 of the subject including arterial blood flow, and the transmitted light or reflected light after being absorbed by this living tissue 6 is provided in the probe. It is detected by the photodiode 7 of the light receiving element.
【0004】このフォトダイオード7の受光出力は差動
増幅器8で増幅され、図5(d)に示す増幅信号K4が
得られる。図中、Rは赤色光の信号であり、IRは赤外
光の信号である。この信号K4は次段の電圧シフト回路
42に入力される。この電圧シフト回路42は、差動増
幅器8の出力端子に直列に接続されたコンデンサ43
と、このコンデンサ43の出力端と接地間に接続された
半導体スイッチ44とにより構成されている。この半導
体スイッチ44は、トランジスタ2,4がともにオフの
とき、すなわち発光ダイオード3,5がともに消灯して
いる期間だけ制御回路41からのオン・オフ制御信号K
3(図5(c))によってオンされ、どちらか一方の発
光ダイオード3または5が発光している期間はオフされ
るようになっている。したがって、発光ダイオード3,
5がともに消灯し、スイッチ44がオンされて接地に短
絡されているときは、電圧シフト回路42の出力は0V
であり、発光ダイオード3または5が発光するときは、
電圧シフト用のコンデンサ43の作用で、半導体スイッ
チ44がオンからオフに切り換えられる瞬間の差動増幅
器8の出力を基準レベルとした受光電圧を取り出すこと
ができる。この動作により外来光によるノイズ成分を除
去できる。The received light output of the photodiode 7 is amplified by the differential amplifier 8 to obtain an amplified signal K4 shown in FIG. 5 (d). In the figure, R is a red light signal, and IR is an infrared light signal. This signal K4 is input to the voltage shift circuit 42 at the next stage. The voltage shift circuit 42 includes a capacitor 43 connected in series to the output terminal of the differential amplifier 8.
And a semiconductor switch 44 connected between the output terminal of the capacitor 43 and the ground. The semiconductor switch 44 has an on / off control signal K from the control circuit 41 only when both the transistors 2 and 4 are off, that is, while the light emitting diodes 3 and 5 are both off.
3 (FIG. 5 (c)), the light emitting diode 3 or 5 is turned off while the light emitting diode 3 or 5 is emitting light. Therefore, the light emitting diode 3,
When both 5 are turned off and the switch 44 is turned on and short-circuited to the ground, the output of the voltage shift circuit 42 is 0V.
And when the light emitting diode 3 or 5 emits light,
Due to the action of the voltage shifting capacitor 43, it is possible to extract the received light voltage with the output of the differential amplifier 8 at the moment when the semiconductor switch 44 is switched from ON to OFF as a reference level. By this operation, the noise component due to the external light can be removed.
【0005】この電圧シフト回路42の出力端子は、ア
ナログスイッチなどからなる信号切換えスイッチ26を
介して赤色受光出力検波用の増幅器29または赤外受光
出力検波用の増幅器32の入力端子に接続される。この
信号切換えスイッチ26は、赤色発光ダイオード3が発
光しているときに演算・制御回路41からの切換え制御
信号K4によって増幅器29が選択されるように切り換
えられ、赤外発光ダイオード5が発光しているときは切
換え制御信号K4によって増幅器32が選択されるよう
に切り換えられる。発光ダイオード3,5が消灯してい
るときは解放となる。これら増幅器29,32の入力端
子には、信号切換えスイッチ26が増幅器29,32を
選択しないときに(解放のときに)電圧を保持するため
のコンデンサ45,46がそれぞれ接続されている。各
増幅器29,32の検波出力信号は、赤色光または赤外
光の生体組織6における吸光度を示す電圧信号となり、
この信号がローパスフィルタ(LPF)33,35を介
してA/D変換器34,36にそれぞれ入力される。デ
ィジタル信号に変換された各検波信号は、演算・制御回
路41に取り込まれ、酸素飽和度Sが算出される。An output terminal of the voltage shift circuit 42 is connected to an input terminal of an amplifier 29 for detecting a red light reception output or an amplifier 32 for detecting an infrared light reception output through a signal changeover switch 26 composed of an analog switch or the like. . The signal changeover switch 26 is changed over so that the amplifier 29 is selected by the changeover control signal K4 from the arithmetic / control circuit 41 when the red light emitting diode 3 is emitting light, and the infrared light emitting diode 5 emits light. If so, the amplifier 32 is switched by the switching control signal K4. It is released when the light emitting diodes 3 and 5 are off. Capacitors 45 and 46 for holding the voltage when the signal changeover switch 26 does not select the amplifier 29 or 32 (at the time of release) are connected to the input terminals of these amplifiers 29 and 32, respectively. The detection output signal of each amplifier 29, 32 becomes a voltage signal indicating the absorbance of the living tissue 6 of red light or infrared light,
This signal is input to the A / D converters 34 and 36 via the low pass filters (LPF) 33 and 35, respectively. Each detection signal converted into a digital signal is taken into the arithmetic / control circuit 41, and the oxygen saturation S is calculated.
【0006】[0006]
【発明が解決しようとする課題】上述した従来のパルス
オキシメータでは、自然光のような一定の外来光が光雑
音としてプローブ内のフォトダイオード7に入光する場
合、図6(a)に示すように差動増幅器8の出力に重畳
するノイズ成分EN は直流となり、電圧シフト回路42
によって増幅器8の出力電圧をこのノイズ分EN だけグ
ランド側(0V側)にシフトすることにより、ノイズの
除去を容易に行なうことができる。図6(b)は、この
直流のノイズ成分EN を除去したあとの電圧シフト回路
42の出力波形を示しており、赤色光による出力電圧分
ER と赤外光による出力電圧分EIRに重畳していたノイ
ズ成分がきれいに取り除かれているのがわかる。In the above-described conventional pulse oximeter, when a constant external light such as natural light enters the photodiode 7 in the probe as optical noise, it is as shown in FIG. 6 (a). The noise component EN superimposed on the output of the differential amplifier 8 becomes DC, and the voltage shift circuit 42
By shifting the output voltage of the amplifier 8 to the ground side (0 V side) by the noise amount EN, noise can be easily removed. FIG. 6B shows the output waveform of the voltage shift circuit 42 after removing the DC noise component EN, which is superimposed on the output voltage component ER for red light and the output voltage component EIR for infrared light. It can be seen that the noise components have been removed cleanly.
【0007】ところで、外来光が自然光ではなく蛍光灯
のような室内照明から発せられる場合は、このような照
明光には商用交流周波数を基本波とした種々の周波数成
分が含まれている。したがって、光雑音にこのような周
波数成分を含む場合、電圧シフト回路42ではノイズの
除去を簡単に行なえなくなる。図7(a)に、このよう
な交流成分のノイズEACが重畳している差動増幅器8の
出力電圧波形を示す。電圧シフト回路42では半導体ス
イッチ44がオンからオフに切り換えられる瞬間の増幅
器8の出力電圧を基準にした電圧シフトを行なうので、
この場合、電圧シフト回路42からはノイズ成分EACの
勾配によって異なる図7(b)に示すような電圧波形が
出力される。この出力波形に示されるように、光雑音が
上り勾配のときは、赤色光による出力電圧分Rと赤外光
による出力電圧分IRにノイズ分N1が加え合わされた
かたちで誤差が混入するようになり、光雑音が下り勾配
のときはノイズ分N2が引かれたかたちで誤差が混入さ
れるようになる。このように外来光に周波数成分が含ま
れる場合、電圧シフト回路42だけでは十分にノイズの
除去を行なえず、ノイズの振幅状態によって異なる誤差
が測定信号に混入してしまうので、正確な酸素飽和度S
の測定を困難にしていた。When the external light is not natural light but is emitted from indoor lighting such as a fluorescent lamp, such illuminating light contains various frequency components having a commercial AC frequency as a fundamental wave. Therefore, when the optical noise includes such a frequency component, the voltage shift circuit 42 cannot easily remove the noise. FIG. 7A shows an output voltage waveform of the differential amplifier 8 on which the noise EAC of such an AC component is superimposed. Since the voltage shift circuit 42 performs voltage shift with reference to the output voltage of the amplifier 8 at the moment when the semiconductor switch 44 is switched from ON to OFF,
In this case, the voltage shift circuit 42 outputs a voltage waveform as shown in FIG. 7B which differs depending on the gradient of the noise component EAC. As shown in this output waveform, when the optical noise has an upward slope, an error is mixed in such a manner that the output voltage component R due to the red light and the output voltage component IR due to the infrared light are added with the noise component N1. Therefore, when the optical noise has a downward gradient, an error is mixed in by subtracting the noise component N2. When the external light contains a frequency component as described above, the voltage shift circuit 42 alone cannot sufficiently remove noise, and an error that differs depending on the amplitude state of noise is mixed in the measurement signal. S
Was difficult to measure.
【0008】そこで、交互に発光される赤色光と赤外光
の発光周期を可能な限り短くすることが考えられる。こ
のようにすることにより、増幅器8の出力信号中に含ま
れる1周期中の光雑音の電圧変化が小さくなって直流に
近づき、電圧シフト回路42でノイズ成分を除去したあ
との誤差を十分に小さくできる。しかし、蛍光灯からは
パルス性のノイズも発しているので、このようなノイズ
成分P1,P2が図7(c)に示すように丁度消灯から
発光に切り換わる境界時間に飛び込むと、電圧シフト回
路42から出力される受光出力信号に図7(d)に示す
ように非常に大きな誤差分が伴うようになり、正確な酸
素飽和度Sを測定できなくなる。N3,N4は誤差とし
て埋もれた信号電圧を示す。Therefore, it is conceivable to shorten the light emission cycle of red light and infrared light emitted alternately as much as possible. By doing so, the voltage change of the optical noise in one cycle included in the output signal of the amplifier 8 becomes small and approaches DC, and the error after the noise component is removed by the voltage shift circuit 42 is sufficiently small. it can. However, since pulsed noise is also emitted from the fluorescent lamp, if such noise components P1 and P2 jump into the boundary time at which light is switched off to light emission as shown in FIG. As shown in FIG. 7D, the received light output signal output from 42 is accompanied by a very large error amount, and the accurate oxygen saturation S cannot be measured. N3 and N4 indicate signal voltages buried as errors.
【0009】このように電圧シフト回路42では、周波
数成分を含む外来光によるノイズ成分を除去することが
難しいが、発光周波数を外来光によるノイズの影響を受
け難い周波数に設定することで、ノイズを除去する方法
が考えられる。蛍光灯から発せられるノイズ光の周波数
成分は、商用交流周波数の整数倍の高調波を含んでお
り、商用周波数が50Hzであると、その整数倍の雑音
周波数が存在している。したがって、交互に発光する赤
と赤外の発光周波数をfHzに設定したとすると、検波
したあとの信号に乗ってくる雑音の周波数は、 (f−n・50)Hz となる。いま、発光周波数をf=575Hzに設定した
すると、光雑音の最小周波数は25Hzとなり、この雑
音周波数は検出しようとする動脈血流による脈動の最大
周波数を上回っており、検波信号をローパスフィルタ3
3,35に通すことによってこのノイズ成分を除去する
ことができる。しかし、この商用交流周波数は各国で公
称50Hzと60Hzが使われているが、多くの国でこ
の商用周波数に誤差が伴っているため、公称の商用周波
数から算出した発光周波数に設定したとしても、光雑音
によるノイズ成分を効果的に除去することは難しい。ま
た、パルスオキシメータが電池駆動機器であると、機器
内に商用交流電源が引き込まれていないため、使用され
ている商用周波数を検出することができず、パルスオキ
シメータ内でノイズの影響を受けない発光周波数に設定
することができなくなる。したがって、このようなノイ
ズ除去方法を採用した場合、電池駆動のパルスオキシメ
ータでは予め使用されている商用周波数が分かっている
地域でなければ、光雑音の除去ができない。As described above, in the voltage shift circuit 42, it is difficult to remove the noise component due to the external light including the frequency component, but by setting the emission frequency to a frequency that is less likely to be affected by the noise due to the external light, the noise is reduced. A method of removing it can be considered. The frequency component of the noise light emitted from the fluorescent lamp contains harmonics that are an integral multiple of the commercial AC frequency, and if the commercial frequency is 50 Hz, an integer multiple of the noise frequency exists. Therefore, assuming that the red and infrared emission frequencies for alternately emitting light are set to fHz, the frequency of noise carried on the signal after detection is (f−n · 50) Hz. Now, when the light emission frequency is set to f = 575 Hz, the minimum frequency of optical noise is 25 Hz, and this noise frequency exceeds the maximum frequency of the pulsation due to the arterial blood flow to be detected, and the detected signal is passed through the low-pass filter 3
This noise component can be removed by passing it through 3, 35. However, this commercial AC frequency is nominally 50 Hz and 60 Hz in each country, but in many countries this commercial frequency has an error, so even if it is set to the emission frequency calculated from the nominal commercial frequency, It is difficult to effectively remove the noise component due to optical noise. If the pulse oximeter is a battery-operated device, the commercial AC power supply is not drawn into the device, so the commercial frequency used cannot be detected, and the pulse oximeter is affected by noise. You will not be able to set a light emission frequency that does not exist. Therefore, when such a noise removing method is adopted, the optical noise cannot be removed by the battery-powered pulse oximeter unless the commercial frequency used in advance is known.
【0010】本発明は、このような従来の技術が有する
課題を解決するために提案されたものであり、周波数成
分を含む外来光がプローブのフォトダイオードに混入す
る場合でも、この光雑音の除去を効果的に行なうことが
できるパルスオキシメータを提供することを目的とす
る。The present invention has been proposed in order to solve the problems of the conventional technique, and even when external light including a frequency component is mixed in the photodiode of the probe, this optical noise is removed. An object of the present invention is to provide a pulse oximeter capable of effectively performing the above.
【0011】[0011]
【課題を解決するための手段】ところで、従来のパルス
オキシメータにおいて、差動増幅器8の次段に低域除去
回路を接続して、外来光からのノイズをこの低域除去回
路で除去したあとに、電圧シフト回路42に信号を入力
する方法が考えられる。この方法により外来光からのノ
イズをある程度除去することができ、低域除去回路の遮
断周波数を上げていくことで、ノイズは除去される方向
に向う。しかし、差動増幅器8から取り出される受光出
力信号(図8(a)参照)のいかんによらず、遮断周波
数を上げていくと、赤外光側の信号が電圧の小さな赤色
光側の信号に引き込まれてしまい、低域除去回路の出力
波形(図8(b)参照)が大きく歪むため、図8(c)
に示すように赤色光を反映する電圧信号Rと赤外光を反
映する電圧信号IRとの分離がうまくいかなくなる。こ
れは、つぎのような理由によるものである。従来のパル
スオキシメータでは、2msecの周期で赤色光および
赤外光の発光ダイオード3,5を交互に発光させてお
り、差動増幅器8からは図5(d)に示したような50
0Hzのキャリアを250Hzの信号A2でAM変調し
たのと等価な信号K4が取り出される。このときの差動
増幅器8の出力信号のパワースペクトル分布を図9に示
す。この図から明らかなように、生体組織6で吸光され
たあとの赤色光と赤外光の受光出力信号に含まれる情報
は、250Hzから750Hzの占有帯幅W2に分布し
ている。したがって、赤色光を反映する電圧信号と赤外
光を反映する電圧信号との分離度を十分にとるには、低
域除去回路の遮断周波数を250Hz以上に上げること
はできず、従来のパルスオキシメータではノイズの除去
を十分に行なえないことになる。By the way, in the conventional pulse oximeter, after a low-pass removing circuit is connected to the next stage of the differential amplifier 8 and noise from external light is removed by this low-pass removing circuit. Another possible method is to input a signal to the voltage shift circuit 42. By this method, the noise from the external light can be removed to some extent, and by increasing the cutoff frequency of the low-frequency removing circuit, the noise is directed to the removal direction. However, regardless of the received light output signal (see FIG. 8A) extracted from the differential amplifier 8, when the cutoff frequency is increased, the infrared light side signal becomes a red light side signal with a small voltage. 8 (c) because the output waveform of the low frequency removing circuit (see FIG. 8 (b)) is greatly distorted because it is pulled in.
As shown in, the separation of the voltage signal R reflecting red light and the voltage signal IR reflecting infrared light is not successful. This is due to the following reasons. In the conventional pulse oximeter, the light emitting diodes 3 and 5 for red light and infrared light are alternately emitted at a cycle of 2 msec, and the differential amplifier 8 outputs 50 as shown in FIG.
A signal K4 equivalent to that obtained by AM-modulating the carrier of 0 Hz with the signal A2 of 250 Hz is extracted. The power spectrum distribution of the output signal of the differential amplifier 8 at this time is shown in FIG. As is clear from this figure, the information contained in the received light output signals of red light and infrared light after being absorbed by the living tissue 6 is distributed in the occupied band width W2 of 250 Hz to 750 Hz. Therefore, in order to obtain a sufficient degree of separation between the voltage signal reflecting the red light and the voltage signal reflecting the infrared light, the cut-off frequency of the low-frequency elimination circuit cannot be increased to 250 Hz or higher, and the conventional pulse oxidizer cannot be used. The meter cannot sufficiently remove the noise.
【0012】そこで、本発明によるパルスオキシメータ
では、動脈血流を含む生体組織に赤色光と赤外光の異な
る2波長の光をそれぞれ照射する第1および第2の光源
と、赤色光の生体組織への照射と遮断を所定周波数でn
回継続して行なう第1のタイミングと、その後赤外光の
生体組織への照射と遮断を所定周波数でn回継続して行
なう第2のタイミングとを繰り返すことで、継続的に赤
色光と赤外光が生体組織に照射されるように第1および
第2の光源を制御する制御手段と、これら第1および第
2の光源から照射された赤色光と赤外光の2波長につい
て生体組織によって吸光されたあとの光出力を検出する
受光素子と、この受光素子から得られる受光信号を増幅
する増幅器と、この増幅器の出力信号から所定の低域遮
断周波数で低域成分を除去する低域除去回路と、この低
域除去回路の出力信号を検波したあとの信号から2波長
についての動脈血流による吸光度の脈動成分の比を算出
するとともに、得られた吸光度の比から動脈血の酸素飽
和度を算出する演算手段と有する構成としてある。ここ
で、第1および第2の光源は赤色発光ダイオードおよび
赤外発光ダイオードで構成でき、これらの光源を制御す
る制御手段と酸素飽和度を算出する演算手段をマイクロ
コンピュータなどからなる演算・制御回路によって構成
できる。Therefore, in the pulse oximeter according to the present invention, first and second light sources for respectively irradiating living tissue including arterial blood flow with two wavelengths of red light and infrared light, and a living body of red light. Irradiation and blocking of tissue at a predetermined frequency
Red light and red light are continuously generated by repeating the first timing for continuously performing the irradiation once and the second timing for continuously irradiating and blocking the infrared light to the biological tissue n times at the predetermined frequency. Control means for controlling the first and second light sources so that the external light is irradiated to the living tissue, and the living tissue for the two wavelengths of red light and infrared light emitted from the first and second light sources. A light receiving element that detects the light output after being absorbed, an amplifier that amplifies the light receiving signal obtained from this light receiving element, and a low band removal that removes low frequency components from the output signal of this amplifier at a predetermined low frequency cutoff frequency. Circuit and the signal after detecting the output signal of this low frequency elimination circuit, the ratio of the pulsating component of the absorbance due to arterial blood flow for two wavelengths is calculated, and the oxygen saturation of arterial blood is calculated from the obtained ratio of the absorbance. Performance It is constituted to have a means. Here, the first and second light sources can be composed of a red light emitting diode and an infrared light emitting diode, and a control means for controlling these light sources and a calculation means for calculating the oxygen saturation are calculation / control circuits including a microcomputer or the like. Can be configured by
【0013】[0013]
【作用】上述した構成によれば、赤色光をn回所定周波
数fo でオン・オフしたあとに、赤外光をn回所定周波
数fo でオン・オフするというタイミングで、生体組織
に2波長の光を照射できるようにしたので、受光素子か
らは周波数fo のキャリアを、2波長についての吸光度
の情報を含むfo /nの周波数でAM変調したのと等価
な信号を取り出すことができる。これにより、キャリア
周波数fo を中心とした吸光度の情報を含む有意な周波
数帯幅(占有帯幅)を狭めることができ、結果的に低域
除去回路の遮断周波数を上げられることで、受光素子に
混入する周波数成分を持つ外来光のノイズを効果的に除
去できる。According to the above-mentioned configuration, the red light is turned on and off n times at the predetermined frequency fo, and then the infrared light is turned on and off n times at the predetermined frequency fo, and the two wavelengths of the biological tissue are emitted. Since light can be emitted, a signal equivalent to that obtained by AM-modulating the carrier having the frequency fo at the frequency fo / n including the information about the absorbance for two wavelengths can be extracted from the light receiving element. As a result, it is possible to narrow a significant frequency band (occupied band width) including the information on the absorbance centering on the carrier frequency fo, and as a result, the cut-off frequency of the low-frequency elimination circuit can be increased, and It is possible to effectively remove the noise of external light having a mixed frequency component.
【0014】[0014]
【実施例】以下、本発明によるパルスオキシメータの具
体的な実施例を図面に基づき詳細に説明する。図1のブ
ロック図に、このパルスオキシメータの一実施例を示
す。なお、説明にあたっては従来例と同様部分に同一符
号を付して重複する部分の説明を一部省略する。この図
で、赤色発光ダイオード3および赤外発光ダイオード5
は,演算・制御回路1からの図2(a)に示す赤色光発
光用制御信号S1および図2(b)に示す赤外光発光用
制御信号S2に基づいて発光と消灯が制御され、これら
発光ダイオード3,5からの赤色光および赤外光が動脈
血流を含む生体組織6に照射される。ここで、赤色発光
ダイオード3がT1の期間(第1のタイミング期間)に
n回(nは2以上の整数)発光と消灯を繰り返したあと
に、赤外発光ダイオード5がつぎのT2の期間(第2の
タイミング期間)にn回発光と消灯を繰り返し、これら
のタイミングが繰り返されることで各発光ダイオード
3,5が継続的に発光される。なお、T1=T2に設定
される。生体組織6に向けて照射された赤色光および赤
外光は、生体組織6に含まれる動脈血流の酸素飽和度S
に応じた波長特有の吸光特性で減光されたあとに、その
透過光または反射光がフォトダイオード7によって受光
される。この実施例では、赤色光および赤外光の透過光
を検出している。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Specific embodiments of the pulse oximeter according to the present invention will be described below in detail with reference to the drawings. An example of this pulse oximeter is shown in the block diagram of FIG. In the description, the same parts as those in the conventional example are designated by the same reference numerals, and part of the description of the overlapping parts will be omitted. In this figure, the red light emitting diode 3 and the infrared light emitting diode 5 are shown.
Is controlled to turn on and off based on the control signal S1 for emitting red light shown in FIG. 2A and the control signal S2 for emitting infrared light shown in FIG. 2B from the arithmetic / control circuit 1. Red light and infrared light from the light emitting diodes 3 and 5 are applied to the living tissue 6 including arterial blood flow. Here, after the red light emitting diode 3 repeatedly emits light n times (n is an integer of 2 or more) and turns off during the period T1 (first timing period), the infrared light emitting diode 5 next period T2 ( In the second timing period), light emission and light extinction are repeated n times, and these light emitting diodes 3 and 5 continuously emit light by repeating these timings. Note that T1 = T2 is set. The red light and the infrared light emitted toward the living tissue 6 are oxygen saturation S of the arterial blood flow contained in the living tissue 6.
After being attenuated by the light absorption characteristic peculiar to the wavelength, the transmitted light or the reflected light is received by the photodiode 7. In this embodiment, transmitted light of red light and infrared light is detected.
【0015】フォトダイオード7の受光出力は、差動増
幅器8で増幅されたあとに、低域除去回路9に入力され
る。図2(c)は、差動増幅器8の出力信号S3を示
す。この低域除去回路9は、増幅器8の出力端子に直列
に接続されたコンデンサ10と、このコンデンサ10の
出力端と接地間に接続された抵抗11と、出力側に直列
に接続されたバッファ増幅器12とから構成されてい
る。この低域除去回路9では、この回路で決められる低
域遮断周波数によって受光信号中の低域成分の除去が行
なわれ、その出力信号S4(図2(d)の信号波形)が
AM検波回路13に送られる。The received light output of the photodiode 7 is amplified by the differential amplifier 8 and then input to the low frequency band removing circuit 9. FIG. 2C shows the output signal S3 of the differential amplifier 8. This low frequency elimination circuit 9 includes a capacitor 10 connected in series to the output terminal of the amplifier 8, a resistor 11 connected between the output terminal of the capacitor 10 and the ground, and a buffer amplifier connected in series to the output side. It is composed of 12 and. The low-frequency removing circuit 9 removes the low-frequency component in the received light signal by the low-frequency cutoff frequency determined by this circuit, and the output signal S4 (signal waveform of FIG. 2 (d)) is detected by the AM detection circuit 13. Sent to.
【0016】このAM検波回路13の構成を説明する
と、バッファ増幅器12の出力端子が抵抗16を介して
差動増幅器14の反転入力端子に接続され、この差動増
幅器14の非反転入力端子が接地されている。差動増幅
器14の出力端子は、ダイオード17のアノードに接続
されているとともに、ダイオード18のカソードに接続
されている。ダイオード17のカソードは、抵抗19を
介して差動増幅器14の反転入力端子に接続され、抵抗
21を介して次段の差動増幅器15の反転入力端子に接
続されている。さらに、このダイオード17のカソード
は抵抗21を介して接地されている。また、ダイオード
18のアノードは抵抗22を介して差動増幅器14の非
反転入力端子に接続され、抵抗24を介して次段の差動
増幅器15の非反転入力端子に接続されている。また、
アノードと抵抗22,24の接続点は、抵抗23を介し
て接地されている。差動増幅器15の非反転入力端子は
抵抗25Aを介して接地されている。また、この差動増
幅器15の出力端子は抵抗25Bを介して反転入力端子
に接続されているとともに、アナログスイッチからなる
信号切換え回路26の入力端子に接続される。なお、各
抵抗には同一の抵抗値ものが使用される。To explain the structure of the AM detection circuit 13, the output terminal of the buffer amplifier 12 is connected to the inverting input terminal of the differential amplifier 14 via the resistor 16, and the non-inverting input terminal of the differential amplifier 14 is grounded. Has been done. The output terminal of the differential amplifier 14 is connected to the anode of the diode 17 and the cathode of the diode 18. The cathode of the diode 17 is connected to the inverting input terminal of the differential amplifier 14 via the resistor 19, and is connected to the inverting input terminal of the differential amplifier 15 at the next stage via the resistor 21. Further, the cathode of the diode 17 is grounded via the resistor 21. The anode of the diode 18 is connected to the non-inverting input terminal of the differential amplifier 14 via the resistor 22, and is connected to the non-inverting input terminal of the differential amplifier 15 of the next stage via the resistor 24. Also,
The connection point between the anode and the resistors 22 and 24 is grounded via the resistor 23. The non-inverting input terminal of the differential amplifier 15 is grounded via the resistor 25A. The output terminal of the differential amplifier 15 is connected to the inverting input terminal via the resistor 25B and also to the input terminal of the signal switching circuit 26 including an analog switch. The resistors having the same resistance value are used.
【0017】このAM検波回路13によって両波検波さ
れた図2(e)に示す赤色光および赤外光の受光信号の
検波信号S5は、演算・制御回路1から出力される図2
(f)に示す切換え制御信号S6によって信号切換え回
路26が切り換えられることで、平滑フィルタを介して
増幅器29,32にそれぞれ分配される。図2(g)に
示す信号S7は分配されたあとの赤色光側の検波信号で
あり、図2(h)に示す信号S8は赤外光側の検波信号
である。なお、平滑フィルタは増幅器29,32の入力
端子にそれぞれ直列に挿入された抵抗27,30と、増
幅器32の入力端子と接地間にそれぞれ接続されたコン
デンサ28,31とからなる。The detection signal S5 of the received light signals of the red light and the infrared light shown in FIG. 2 (e), which are both detected by the AM detection circuit 13, are output from the arithmetic / control circuit 1.
By switching the signal switching circuit 26 by the switching control signal S6 shown in (f), the signals are distributed to the amplifiers 29 and 32 through the smoothing filters. The signal S7 shown in FIG. 2 (g) is the detection signal on the red light side after being distributed, and the signal S8 shown in FIG. 2 (h) is the detection signal on the infrared light side. The smoothing filter includes resistors 27 and 30 inserted in series to the input terminals of the amplifiers 29 and 32, and capacitors 28 and 31 connected between the input terminal of the amplifier 32 and the ground.
【0018】増幅器29,32を通った赤色光の検波信
号および赤外光の検波信号は、各光が生体組織6を透過
したあとの吸光度の情報を反映した電圧信号である。こ
れらの検波信号はローパスフィルタ33,35を介して
A/D変換器34,36に入力され、ディジタル信号に
変換されたあとに演算・制御回路1に取り込まれる。こ
の演算・制御回路1では、赤色光および赤外光の吸光度
の脈動成分の比Φを算出し、この吸光度の比Φから酸素
飽和度Sを求める演算を行なう。The red light detection signal and the infrared light detection signal that have passed through the amplifiers 29 and 32 are voltage signals reflecting the information on the absorbance after each light has passed through the living tissue 6. These detected signals are input to the A / D converters 34 and 36 through the low pass filters 33 and 35, converted into digital signals, and then taken into the arithmetic / control circuit 1. The calculation / control circuit 1 calculates the ratio Φ of the pulsating components of the absorbance of red light and infrared light, and calculates the oxygen saturation S from the ratio Φ of the absorbance.
【0019】このようにこのパルスオキシメータでは、
各発光制御信号S1,S2に基づいて赤色発光ダイオー
ド3がn回発光と消灯を繰り返したあとに、その後の休
止期間に赤外発光ダイオード5がn回発光と消灯を繰り
返すというタイミングで各発光ダイオード3,5を発光
させているので、増幅器8からは図2(c)に示したよ
うな出力電圧波形が取り出される。いま、発光期間にお
ける各発光ダイオード3,5の発光周波数f0 を500
Hzとすると、増幅器8の出力信号S3は500Hzの
キャリアを250/nHzの信号A1でAM変調したの
と等価な信号となる。このときの増幅器8の出力信号S
3のパワースペクトルを図3に示す。この図から明らか
なように増幅器8の出力信号は、500Hzのキャリア
周波数f0 を中心にして500−(250/n)Hzの
周波数f1 の下側帯波から500+(250/n)Hz
の周波数f2の上側帯波の範囲に分布しており、情報を
持つスペクトルの占有帯幅W1は500/nHzとなっ
ている。したがって、この占有帯幅W1は従来に比べて
1/nに縮退している。なお、fa ,fb は、従来の下
側帯波と上側帯波を示す。これにより、低域除去回路9
の低域遮断周波数を上げても、有用な信号成分が除去さ
れてしまうことはなく、この低域除去回路9によって蛍
光灯などの周波数成分を含む外来光のノイズを十分に除
去することが可能となる。Thus, in this pulse oximeter,
After the red light emitting diode 3 repeatedly emits and turns off the light n times based on the light emission control signals S1 and S2, the infrared light emitting diode 5 repeats the light emitting and extinction n times during the rest period. Since 3 and 5 are emitting light, the output voltage waveform as shown in FIG. Now, the light emission frequency f0 of each light emitting diode 3, 5 in the light emission period is set to 500
If the frequency is set to Hz, the output signal S3 of the amplifier 8 becomes a signal equivalent to that obtained by AM-modulating the carrier of 500 Hz with the signal A1 of 250 / nHz. Output signal S of amplifier 8 at this time
The power spectrum of No. 3 is shown in FIG. As is clear from this figure, the output signal of the amplifier 8 is 500+ (250 / n) Hz from the lower sideband of the frequency f1 of 500- (250 / n) Hz centered on the carrier frequency f0 of 500 Hz.
Is distributed in the range of the upper sideband of the frequency f2, and the occupied band width W1 of the spectrum having information is 500 / nHz. Therefore, the occupied band width W1 is reduced to 1 / n as compared with the conventional one. Note that fa and fb indicate the conventional lower sideband and upper sideband. As a result, the low frequency removing circuit 9
Even if the low cutoff frequency of is increased, useful signal components are not removed, and the low frequency removal circuit 9 can sufficiently remove the noise of external light including frequency components of fluorescent lamps and the like. Becomes
【0020】つぎに、各発光ダイオード3,5の発光周
波数f0 を500Hzから数kHzに高めた場合につい
て説明する。この発光周波数をたとえば10kHzに設
定し、連続した発光回数nをたとえば20回とすると、
占有帯幅W1は500Hzとなり、下側帯波の周波数f
1 は9.75kHzとなる。これにより、蛍光灯などの
外来光に数kHzのノイズ成分が含まれていたとして
も、低域除去回路9の遮断周波数を9kHz以上に設定
することができ、周波数成分を含む外来光のノイズを完
全に除去することができる。Next, the case where the light emitting frequency f0 of each of the light emitting diodes 3 and 5 is increased from 500 Hz to several kHz will be described. If this light emission frequency is set to, for example, 10 kHz and the number of consecutive light emission times n is, for example, 20 times,
The occupied band width W1 is 500 Hz, and the frequency f of the lower sideband is
1 becomes 9.75 kHz. As a result, even if external light such as a fluorescent lamp contains a noise component of several kHz, the cutoff frequency of the low-frequency elimination circuit 9 can be set to 9 kHz or higher, and the noise of the external light including the frequency component can be reduced. Can be completely removed.
【0021】なお、図1に示したパルスオキシメータで
は、低域除去回路9の出力信号S4をAM検波回路13
に入力する構成となっているが、低域除去後の信号S4
を図4に示した電圧シフト回路42に通し、その後信号
切換え回路26に入力するような回路構成も可能であ
る。In the pulse oximeter shown in FIG. 1, the output signal S4 of the low frequency band removing circuit 9 is detected by the AM detecting circuit 13.
The signal S4 after the low frequency band is removed
Is also possible through the voltage shift circuit 42 shown in FIG. 4 and then input to the signal switching circuit 26.
【0022】[0022]
【発明の効果】以上説明したように本発明によれば、赤
と赤外の2つの波長の光を生体組織に時分割に入射して
異なる波長の吸光度の情報を得るにあたって、赤色光を
所定の周波数f0 で断続的にn回入光したあとに、赤外
光を同周波数f0 で断続的にn回入光するというタイミ
ングで、2波長の光を生体組織に照射しているため、受
光素子からは、中心周波数f0 に伴う吸光度の情報を含
む周波数分の占有帯幅を狭めた受光信号を取り出すこと
ができ、結果的に低域除去回路の遮断周波数を上げるこ
とができる。これにより、受光素子に混入した周波数成
分を含む外来光のノイズをこの低域除去回路によって効
果的に除去することができ、従来よりも高精度に酸素飽
和度Sの測定を行なうことができる。As described above, according to the present invention, when red light and infrared light having two wavelengths are incident on living tissue in a time division manner to obtain information on the absorbance of different wavelengths, red light is predetermined. Since the infrared light is intermittently incident at the frequency f0 of n times and then the infrared light is intermittently incident at the same frequency f0 n times, the biological tissue is irradiated with light of two wavelengths. From the element, it is possible to take out a received light signal in which the occupied bandwidth for the frequency including the information on the absorbance associated with the center frequency f0 is narrowed, and as a result, the cut-off frequency of the low frequency elimination circuit can be increased. As a result, the noise of the external light including the frequency component mixed in the light receiving element can be effectively removed by this low-frequency removing circuit, and the oxygen saturation S can be measured with higher accuracy than before.
【図面の簡単な説明】[Brief description of drawings]
【図1】本発明によるパルスオキシメータの一実施例を
示す回路図である。FIG. 1 is a circuit diagram showing an embodiment of a pulse oximeter according to the present invention.
【図2】図1のパルスオキシメータの動作を説明するた
めの波形図である。FIG. 2 is a waveform diagram for explaining the operation of the pulse oximeter of FIG.
【図3】受光出力信号のパワースペクトルを示す図であ
る。FIG. 3 is a diagram showing a power spectrum of a received light output signal.
【図4】従来のパルスオキシメータを示す回路図であ
る。FIG. 4 is a circuit diagram showing a conventional pulse oximeter.
【図5】従来のパルスオキシメータの動作を説明するた
めの波形図である。FIG. 5 is a waveform diagram for explaining the operation of a conventional pulse oximeter.
【図6】光雑音が直流成分である場合の電圧シフト回路
の動作を説明するための波形図である。FIG. 6 is a waveform diagram for explaining the operation of the voltage shift circuit when optical noise is a DC component.
【図7】光雑音が周波数成分やパルス成分を含む場合の
電圧シフト回路の動作を説明するための波形図である。FIG. 7 is a waveform diagram for explaining the operation of the voltage shift circuit when the optical noise includes a frequency component and a pulse component.
【図8】従来のパルスオキシメータに低域除去回路を採
用した場合の不具合点を説明するための波形図である。FIG. 8 is a waveform diagram for explaining a problem when a low-frequency removing circuit is used in a conventional pulse oximeter.
【図9】従来のパルスオキシメータで受光出力に現れる
パワースペクトルを示す図である。FIG. 9 is a diagram showing a power spectrum appearing in a light reception output by a conventional pulse oximeter.
1 演算・制御増幅回路 3 赤色発光ダイオード 5 赤外発光ダイオード 6 生体組織 7 フォトダイオード 8 差動増幅器 9 低域除去回路 13 AM検波回路 26 信号切換え回路 29,32 増幅器 33,35 ローパスフィルタ 34,35 A/D変換器 1 Calculation / Control Amplification Circuit 3 Red Light Emitting Diode 5 Infrared Light Emitting Diode 6 Living Tissue 7 Photodiode 8 Differential Amplifier 9 Low Frequency Removal Circuit 13 AM Detection Circuit 26 Signal Switching Circuit 29, 32 Amplifier 33, 35 Low Pass Filter 34, 35 A / D converter
Claims (1)
光の異なる2波長の光をそれぞれ照射する第1および第
2の光源と、 赤色光の生体組織への照射と遮断を所定周波数でn回継
続して行なう第1のタイミングと、その後赤外光の生体
組織への照射と遮断を所定周波数でn回継続して行なう
第2のタイミングとを繰り返すことで、継続的に赤色光
と赤外光が生体組織に照射されるように第1および第2
の光源を制御する制御手段と、 これら第1および第2の光源から照射された赤色光と赤
外光の2波長について生体組織によって吸光されたあと
の光出力を検出する受光素子と、 この受光素子から得られる受光信号を増幅する増幅器
と、 この増幅器の出力信号から所定の低域遮断周波数で低域
成分を除去する低域除去回路と、 この低域除去回路の出力信号を検波したあとの信号から
2波長についての動脈血流による吸光度の脈動成分の比
を算出するとともに、得られた吸光度の比から動脈血の
酸素飽和度を算出する演算手段とを有することを特徴と
するパルスオキシメータ。1. A first and a second light source for respectively irradiating living tissue including arterial blood flow with light of two different wavelengths, red light and infrared light, and predetermined irradiation and blocking of the living tissue with red light. By repeating the first timing for continuously performing n times at the frequency and the second timing for continuously performing irradiation and blocking of the infrared light to the biological tissue n times at the predetermined frequency, the red color is continuously obtained. 1st and 2nd so that living tissue is irradiated with light and infrared light
Means for controlling the light source, a light receiving element for detecting the light output after being absorbed by the biological tissue for the two wavelengths of red light and infrared light emitted from the first and second light sources, and An amplifier that amplifies the received light signal obtained from the device, a low-frequency removing circuit that removes low-frequency components from the output signal of this amplifier at a predetermined low-frequency cutoff frequency, and an output signal of this low-frequency removing circuit after detection. A pulse oximeter, comprising: a calculation means for calculating the ratio of the pulsating component of the absorbance due to arterial blood flow for two wavelengths from the signal, and the oxygen saturation of arterial blood from the obtained ratio of the absorbance.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP04249622A JP3116255B2 (en) | 1992-09-18 | 1992-09-18 | Pulse oximeter |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP04249622A JP3116255B2 (en) | 1992-09-18 | 1992-09-18 | Pulse oximeter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0698881A true JPH0698881A (en) | 1994-04-12 |
| JP3116255B2 JP3116255B2 (en) | 2000-12-11 |
Family
ID=17195770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP04249622A Expired - Lifetime JP3116255B2 (en) | 1992-09-18 | 1992-09-18 | Pulse oximeter |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3116255B2 (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7684842B2 (en) | 2006-09-29 | 2010-03-23 | Nellcor Puritan Bennett Llc | System and method for preventing sensor misuse |
| US8219170B2 (en) | 2006-09-20 | 2012-07-10 | Nellcor Puritan Bennett Llc | System and method for practicing spectrophotometry using light emitting nanostructure devices |
| US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
| US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
| US8315685B2 (en) | 2006-09-27 | 2012-11-20 | Nellcor Puritan Bennett Llc | Flexible medical sensor enclosure |
| KR101320452B1 (en) * | 2012-04-12 | 2013-11-06 | 주식회사 메디칼써프라이 | A system with improved accuracy for measuring oxygen saturation |
| US9597033B2 (en) | 2007-06-06 | 2017-03-21 | Sony Corporation | Biological-information obtaining apparatus and method thereof |
| JP2017516533A (en) * | 2014-05-22 | 2017-06-22 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Method and apparatus for optical sensing of tissue variation with increased accuracy |
| US9770210B2 (en) | 2011-09-23 | 2017-09-26 | Nellcor Puritan Bennett Ireland | Systems and methods for analyzing a physiological sensor signal |
| US9895068B2 (en) | 2008-06-30 | 2018-02-20 | Covidien Lp | Pulse oximeter with wait-time indication |
| WO2019181267A1 (en) | 2018-03-20 | 2019-09-26 | Dynamic Brain Lab合同会社 | Biological information measurement device |
| WO2019181268A1 (en) | 2018-03-20 | 2019-09-26 | Dynamic Brain Lab合同会社 | Biological information measurement device |
| JP2020146364A (en) * | 2019-03-15 | 2020-09-17 | 興和株式会社 | Blood component measuring device, control method of blood component measuring device, and control program of blood component measuring device |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6018673A (en) | 1996-10-10 | 2000-01-25 | Nellcor Puritan Bennett Incorporated | Motion compatible sensor for non-invasive optical blood analysis |
| US7162288B2 (en) | 2004-02-25 | 2007-01-09 | Nellcor Purtain Bennett Incorporated | Techniques for detecting heart pulses and reducing power consumption in sensors |
| US7190985B2 (en) | 2004-02-25 | 2007-03-13 | Nellcor Puritan Bennett Inc. | Oximeter ambient light cancellation |
| US7590439B2 (en) | 2005-08-08 | 2009-09-15 | Nellcor Puritan Bennett Llc | Bi-stable medical sensor and technique for using the same |
| US7657294B2 (en) | 2005-08-08 | 2010-02-02 | Nellcor Puritan Bennett Llc | Compliant diaphragm medical sensor and technique for using the same |
| US7904130B2 (en) | 2005-09-29 | 2011-03-08 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
| US7869850B2 (en) | 2005-09-29 | 2011-01-11 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
| US7899510B2 (en) | 2005-09-29 | 2011-03-01 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
| US7881762B2 (en) | 2005-09-30 | 2011-02-01 | Nellcor Puritan Bennett Llc | Clip-style medical sensor and technique for using the same |
| US7483731B2 (en) | 2005-09-30 | 2009-01-27 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
| US7477924B2 (en) | 2006-05-02 | 2009-01-13 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
| US7522948B2 (en) | 2006-05-02 | 2009-04-21 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
| US8073518B2 (en) | 2006-05-02 | 2011-12-06 | Nellcor Puritan Bennett Llc | Clip-style medical sensor and technique for using the same |
| US8145288B2 (en) | 2006-08-22 | 2012-03-27 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
| US8396527B2 (en) | 2006-09-22 | 2013-03-12 | Covidien Lp | Medical sensor for reducing signal artifacts and technique for using the same |
| US8195264B2 (en) | 2006-09-22 | 2012-06-05 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
| US8175671B2 (en) | 2006-09-22 | 2012-05-08 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
| US7869849B2 (en) | 2006-09-26 | 2011-01-11 | Nellcor Puritan Bennett Llc | Opaque, electrically nonconductive region on a medical sensor |
| US7894869B2 (en) | 2007-03-09 | 2011-02-22 | Nellcor Puritan Bennett Llc | Multiple configuration medical sensor and technique for using the same |
| US20100030040A1 (en) | 2008-08-04 | 2010-02-04 | Masimo Laboratories, Inc. | Multi-stream data collection system for noninvasive measurement of blood constituents |
| US8437825B2 (en) | 2008-07-03 | 2013-05-07 | Cercacor Laboratories, Inc. | Contoured protrusion for improving spectroscopic measurement of blood constituents |
| CN109688928A (en) | 2016-09-14 | 2019-04-26 | 动力大脑实验室合同会社 | Biological information measuring device |
| WO2023287789A1 (en) | 2021-07-13 | 2023-01-19 | Masimo Corporation | Wearable device with physiological parameters monitoring |
-
1992
- 1992-09-18 JP JP04249622A patent/JP3116255B2/en not_active Expired - Lifetime
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8219170B2 (en) | 2006-09-20 | 2012-07-10 | Nellcor Puritan Bennett Llc | System and method for practicing spectrophotometry using light emitting nanostructure devices |
| US8315685B2 (en) | 2006-09-27 | 2012-11-20 | Nellcor Puritan Bennett Llc | Flexible medical sensor enclosure |
| US7684842B2 (en) | 2006-09-29 | 2010-03-23 | Nellcor Puritan Bennett Llc | System and method for preventing sensor misuse |
| US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
| US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
| US9597033B2 (en) | 2007-06-06 | 2017-03-21 | Sony Corporation | Biological-information obtaining apparatus and method thereof |
| US9895068B2 (en) | 2008-06-30 | 2018-02-20 | Covidien Lp | Pulse oximeter with wait-time indication |
| US9770210B2 (en) | 2011-09-23 | 2017-09-26 | Nellcor Puritan Bennett Ireland | Systems and methods for analyzing a physiological sensor signal |
| KR101320452B1 (en) * | 2012-04-12 | 2013-11-06 | 주식회사 메디칼써프라이 | A system with improved accuracy for measuring oxygen saturation |
| JP2017516533A (en) * | 2014-05-22 | 2017-06-22 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Method and apparatus for optical sensing of tissue variation with increased accuracy |
| WO2019181267A1 (en) | 2018-03-20 | 2019-09-26 | Dynamic Brain Lab合同会社 | Biological information measurement device |
| WO2019181268A1 (en) | 2018-03-20 | 2019-09-26 | Dynamic Brain Lab合同会社 | Biological information measurement device |
| JP2020146364A (en) * | 2019-03-15 | 2020-09-17 | 興和株式会社 | Blood component measuring device, control method of blood component measuring device, and control program of blood component measuring device |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3116255B2 (en) | 2000-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3116255B2 (en) | Pulse oximeter | |
| EP0734223B1 (en) | Medical sensor with amplitude independent output | |
| US4807630A (en) | Apparatus and method for use in pulse oximeters | |
| US5995858A (en) | Pulse oximeter | |
| JP3944448B2 (en) | Blood measuring device | |
| US10433738B2 (en) | Method and apparatus for optical sensing of tissue variation at increased accuracy | |
| US7062307B2 (en) | Oversampling pulse oximeter | |
| US6381479B1 (en) | Pulse oximeter with improved DC and low frequency rejection | |
| CA1326267C (en) | Pulse oximetry system | |
| CA2260928C (en) | Direct to digital oximeter | |
| US4848901A (en) | Pulse oximeter sensor control system | |
| JPH06169902A (en) | Pulse type non-invasion type oxymeter and technology for measuring it | |
| US11344234B2 (en) | Circuit arrangement for an optical monitoring system and method for optical monitoring | |
| JP2003153881A (en) | Blood component measuring instrument | |
| CN108245174B (en) | An analog circuit front-end module and detection method of a reflective photoelectric volumetric wave | |
| CN103169478A (en) | Blood oxygen measurement device | |
| JP2693958B2 (en) | Oximeter and method for measuring blood components in arteries | |
| JP2017140202A (en) | Pulse wave detection device | |
| JPH03170866A (en) | Method and apparatus for measuring degree of saturation of oxygen | |
| JP2003153882A (en) | Blood component measuring instrument | |
| JP2017064115A (en) | Biological body measurement device and biological body measurement system | |
| JP6137321B2 (en) | Biosensor | |
| US12232855B2 (en) | Measurement device and measurement method | |
| US20150141840A1 (en) | Biological sensor | |
| JPS63290542A (en) | Pulse wave monitor apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20000822 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081006 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091006 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101006 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101006 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111006 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111006 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121006 Year of fee payment: 12 |
|
| EXPY | Cancellation because of completion of term |